iRhythm Technologies, Inc.

LSE:0A7L Stock Report

Market Cap: US$2.2b

iRhythm Technologies Management

Management criteria checks 2/4

iRhythm Technologies' CEO is Quentin Blackford, appointed in Oct 2021, has a tenure of 2.92 years. total yearly compensation is $16.60M, comprised of 4.1% salary and 95.9% bonuses, including company stock and options. directly owns 0.23% of the company’s shares, worth $5.06M. The average tenure of the management team and the board of directors is 2.4 years and 7.2 years respectively.

Key information

Quentin Blackford

Chief executive officer

US$16.6m

Total compensation

CEO salary percentage4.1%
CEO tenure2.9yrs
CEO ownership0.2%
Management average tenure2.4yrs
Board average tenure7.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Quentin Blackford's remuneration changed compared to iRhythm Technologies's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$132m

Mar 31 2024n/an/a

-US$130m

Dec 31 2023US$17mUS$677k

-US$123m

Sep 30 2023n/an/a

-US$105m

Jun 30 2023n/an/a

-US$99m

Mar 31 2023n/an/a

-US$105m

Dec 31 2022US$8mUS$650k

-US$116m

Sep 30 2022n/an/a

-US$128m

Jun 30 2022n/an/a

-US$131m

Mar 31 2022n/an/a

-US$124m

Dec 31 2021US$10mUS$163k

-US$101m

Compensation vs Market: Quentin's total compensation ($USD16.60M) is above average for companies of similar size in the UK market ($USD2.27M).

Compensation vs Earnings: Quentin's compensation has increased whilst the company is unprofitable.


CEO

Quentin Blackford (45 yo)

2.9yrs

Tenure

US$16,595,149

Compensation

Mr. Quentin S. Blackford serves as an Independent Director of Paragon 28, Inc. since August 1, 2022. He serves as President and Chief Executive Officer since October 04, 2021 and serves as Director at iRhy...


Leadership Team

NamePositionTenureCompensationOwnership
Quentin Blackford
President2.9yrsUS$16.60m0.23%
$ 5.1m
Minang Turakhia
Chief Medical & Scientific Officer and Executive VP of Product Innovation2.4yrsUS$5.32m0.016%
$ 339.3k
Patrick Murphy
Chief Business & Legal Officer2.8yrsUS$5.33m0.031%
$ 668.6k
Chad Patterson
Chief Commercial Officer2.2yrsUS$5.77m0.025%
$ 550.3k
Mervin Smith
Executive Vice President of Business Operations1.2yrsno data0.0023%
$ 51.2k
Marc Rosenbaum
Senior VP of Finance & Chief Accounting Officer1.1yrsno data0.0029%
$ 63.6k
Daniel Wilson
Executive VP of Corporate Development & Investor Relations5.3yrsUS$3.54m0.098%
$ 2.1m
Sumi Shrishrimal
Executive VP & Chief Risk Officer2.3yrsno data0.075%
$ 1.6m
Stephanie Zhadkevich
Director of Investor Relationsno datano datano data

2.4yrs

Average Tenure

45yo

Average Age

Experienced Management: 0A7L's management team is considered experienced (2.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Quentin Blackford
President2.7yrsUS$16.60m0.23%
$ 5.1m
Ralph Snyderman
Independent Director7.2yrsUS$233.12k0.032%
$ 706.2k
Michael Mirro
Medical Director & Member of Scientific Advisory Boardno datano datano data
Bruce Bodaken
Independent Director7.2yrsUS$240.25k0.030%
$ 660.8k
Abhijit Talwalkar
Independent Chairman8.3yrsUS$286.74k0.033%
$ 730.5k
R. Mead
Medical Director & Member of Scientific Advisory Boardno datano datano data
James Quinn
Member of Scientific Advisory Boardno datano datano data
Cathleen Noel Merz
Independent Director6.4yrsUS$230.62k0.018%
$ 404.3k
Mark Rubash
Independent Director8.5yrsUS$248.12k0.034%
$ 741.2k
Mehdi Razavi
Medical Director & Member of Scientific Advisory Boardno datano datano data
Karen Ling
Independent Director2.8yrsUS$239.97k0.020%
$ 445.8k
Jay Alexander
Medical Director & Member of Scientific Advisory Boardno datano datano data

7.2yrs

Average Tenure

67yo

Average Age

Experienced Board: 0A7L's board of directors are considered experienced (7.2 years average tenure).